Profile
Arthur J.
Fratamico is currently an Independent Director at Panbela Therapeutics, Inc., a position held since 2019.
Formerly, Mr. Fratamico was President & Chief Executive Officer at Radiant Biotherapeutics, Inc., Vice President-Business Development & Licensing at MGI PHARMA, Inc., Chief Business Officer at Flexion Therapeutics, Inc. from 2012 to 2014, Chief Business Officer at Vitae Pharmaceuticals LLC from 2014 to 2016, Vice President-Business & Strategic Development at Gemin X Pharmaceuticals US, Inc. from 2009 to 2010, Principal at Hoechst Marion Roussel, Inc., Chief Business Officer at Trevena, Inc., and Chief Business Officer at Galera Therapeutics, Inc. Education includes an MBA from Drexel University and undergraduate studies at Philadelphia College of Pharmacy.
Arthur Fratamico active positions
| Companies | Position | Start |
|---|---|---|
| SUN BIOPHARMA INC | Director/Board Member | 2019-12-15 |
Former positions of Arthur Fratamico
| Companies | Position | End |
|---|---|---|
| VITAE PHARMACEUTICALS INC | Corporate Officer/Principal | 2016-12-24 |
| FLEXION THERAPEUTICS, INC. | Corporate Officer/Principal | 2013-12-31 |
Radiant Biotherapeutics, Inc.
Radiant Biotherapeutics, Inc. BiotechnologyHealth Technology Develops multi-valent and specific bio therapeutics solutions | Chief Executive Officer | - |
| GALERA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| TREVENA, INC. | Corporate Officer/Principal | - |
Training of Arthur Fratamico
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology Develops. manufactures & markets pharmaceutical and medical products for therapeutic markets | Health Technology |
Flexion Therapeutics, Inc.
Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Galera Therapeutics, Inc.
Galera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy | Health Technology |
Drexel University
Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vitae Pharmaceuticals LLC
Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops small molecule compounds | Health Technology |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products | Health Technology |
Hoechst Marion Roussel, Inc.
Hoechst Marion Roussel, Inc. Pharmaceuticals: GenericHealth Technology Develops, manufactures and sells generic pharmaceutical products | Health Technology |
Trevena, Inc.
Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system | Health Technology |
Philadelphia College of Pharmacy
Philadelphia College of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Panbela Therapeutics, Inc.
Panbela Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for pancreatic cancer and chronic pancreatitis | Health Technology |
Radiant Biotherapeutics, Inc.
Radiant Biotherapeutics, Inc. BiotechnologyHealth Technology Develops multi-valent and specific bio therapeutics solutions | Health Technology |
- Stock Market
- Insiders
- Arthur Fratamico
















